N/A
N=536
Promoting Informed Decisions About Cancer Screening in Older Adults
Colorectal Cancer Screening
Bottom Line
View on ClinicalTrials.gov: NCT03959696 ↗Enrolled (actual)
536
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcome: Primary: Shared Decision Making Process (SDMP) Scale Score — 1.1; 1.5 Score on a scale — p=.011
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Notification (Behavioral); Training (Behavioral)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- Massachusetts General Hospital
- Primary completion
- Apr 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Shared Decision Making Process (SDMP) Scale Score |
1.1; 1.5 | .011 sig |
| SECONDARY Patients' Colorectal Cancer Screening Knowledge Score |
61; 63 | 0.36 |
| SECONDARY Percentage of Patients Who Received Preferred Approach to Colorectal Cancer Testing |
103; 115 | 0.47 |
| SECONDARY Physician's Shared Decision Making Skills |
5.5; 6.1 | 0.19 |
| SECONDARY Colorectal Cancer Screening Rates |
29.1; 38.6 | 0.032 sig |
| SECONDARY Clinician Satisfaction With the Visit |
138; 171 | 0.64 |
Summary
This project aims to examine the impact of different interventions designed to help individualize colorectal cancer (CRC) screening decisions in adults aged 76-85. Clinicians will be assigned by chance to one of two arms. In the Intervention arm, clinician participants will complete a training course and will also be notified of patients in the target age group who are due for a discussion about CRC screening. In the Comparator arm, clinician participants will be notified of their patients in the target age group with an upcoming visit who are due for a discussion about CRC screening. The investigators expect that patients seen by clinicians in the intervention arm will report more involvement in the decision making process, be more knowledgeable about the risks and benefits of CRC screening, and will have better quality decisions. Further, the investigators expect that the physicians in the intervention arm will have greater confidence in and demonstrate more skills for conducting shared decision making conversations as compared to those in the control arm.
Eligibility Criteria
For Clinicians, eligibility will not be decided by sex, gender, or age
Inclusion Criteria for clinicians:
- Primary Care Physician (MD or NP)
- Manages a panel of patients
- Has ≥20 potentially eligible patients (age 76-85 and due for colorectal cancer screening) in their panel
- Practices at participating site
Exclusion Criteria for clinicians:
- Residents, medical students
- Does not manage panel of patients (e.g. urgent care clinician)
Patients of participating clinicians will be enrolled to evaluate the impact of the interventions.
Inclusion Criteria for patients:
- Adults, age 76-85 at the time of the scheduled visit
- Scheduled for non-urgent office visit with a participating clinician during the study period
- Due or overdue for colorectal cancer screening (e.g. never been screened, 1 year or less to follow-up interval indicated on previous test).
Exclusion Criteria for patients:
- Prior diagnosis of colon or rectal cancer, inflammatory bowel disease or genetic disorder that raises CRC risk (e.g. hereditary non-polyposis CRC and familial adenomatous polyposis)
- Unable to consent for themselves (e.g. moderate to severe dementia or other major cognitive limitations)
- Unable to read or write in English or Spanish
Data sourced from ClinicalTrials.gov (NCT03959696). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.